Introduction
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acid strand which allows for precise localization of a specific segment of nucleic acid within a histologic section. The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached. Visualization of the reporter molecule allows to localize DNA or RNA sequences in heterogeneous cell populations including tissue samples and environmental samples, Riboprobes also allow to localize and assess the degree of gene expression.
4. Detection and data analyze
Why Leading Biology
With over 5 years of experience in custom antibodies, we offer numerous benefits for developing your custom antibody:
• Our industry leading titer guarantees of 1:50,000 eliminate the risk of not obtaining antibodies against peptide antigens.
• Our economies of scale allow us to pass cost savings to you and help maximize your budget.
• 100% of services are transparent throughout.
• Antibodies from our facility have been cited in many published research papers.
• By outsourcing antibody production and characterization needs to us, you can spend more time focused on your research.
• Our ideal location in California ensures that animals benefit from outdoor facilities and mild year-round temperatures.
• Confidentiality is a top priority for all projects. Antibodies that we manufacture belong to you and will not be commercialized.
Contact Information
Please obtain a quote before ordering, and refer to the quote number when you place an order.
Orders are typically confirmed within 12 hours.
Have a Question? Email us info@leadingbiology.com
Order Products: Order Related Products
By Phone: 1-661-524(LBI)-0262 (USA)
No | Headline | Click | Author | Date |
1 | Genome Editing: Which Should I Choose, TALEN or CRISPR? | 1609 | Leading Biology | 2020-01-03 |
2 | TALEN - Transcription activator-like effector nuclease | 2120 | Leading Biology | 2020-01-02 |
3 | Microorganisms Gene Modification Services | 1347 | Leading Biology | 2019-12-30 |
4 | CRISPR-CAS Technology | 1705 | Leading Biology | 2019-12-30 |
5 | Transgenic Plants Construction | 1644 | Leading Biology | 2019-12-30 |
6 | In Situ Hybridization | 2485 | Leading Biology | 2018-01-26 |